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Poster Session II S361performed when indicated clinically. CT scan of lung was performed
to confirm the diagnosis of lung GVHD and to exclude other infec-
tious causes. Bronchoscopic lavage was performed to exclude poten-
tial infectious cause if needed. Potential clinical risk factors for lung
GVHD were examined including conditioning, age, gender, source
of stem cell, diagnosis, disease status and previous episode of acute
GVHD.
Results:With median follow up of 1,122 days, 68 patients (16.9%)
had a diagnosis of chronic GVHD of lung with median onset of 349
days (range 71-1,880 days; 95% CI [299-398 days]), 53(78%) of
whom patients received myeloablative conditioning. Fifty
one(75%) patients received matched sibling donor transplant versus
17(25%) patients received unrelated donor. Overall survival rates re-
mained similar in both cohorts.
In the univariate analyses, other clinical risk factors were not asso-
ciated with the risk of chronic GVHD of lung: conditioning (p 5
0.9), age with cut off of 60 years (p5 0.4), donor type (p5 0.5), grade
II-IV acute GVHD (p 5 0.7), grade III-IV acute GVHD(p 5 0.4),
development of CMV reactivation (p 5 0.6). However, incidence
of chronic GVHD lung was significantly higher in the group receiv-
ing PBSC (13.86 2.4% at 1 year; 23.063.2% at 2 years) than in those
receiving BM (6.862.5% at 1 year; 1663.8% at 2 years; p 5 0.02,
hazard ratio 1.937, 95%CI [1.100-3.410]). Multivariate analyses
also confirmed PBSC transplantation as an independent risk factor
for chronic GVHD of lung (p 5 0.005, hazard ratio 2.359, 95%CI
[1.290-4.314]).
Conclusion: The use of PBSC increases the risk of lung GVHD
compared to the use of BM for allogeneic HCT. Closer monitoring
is warranted to detect lung GVHD early after PBSCT.425
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Introduction: Rapamycin (RAPA) inhibits the serine/threonine ki-
nase mammalian Target of Rapamycin, a crucial immune regulator.
Dendritic cells (DC) exposed to RAPA (RAPA-DC) enrich for
CD4+FoxP3+ regulatory T cells and induce alloreactive T cell apo-
ptosis. RAPA-DC promote experimental allograft survival, yet para-
doxically secrete increased IL-12, which is central for the generation
of IFN-g+CD4+ T helper type 1 cells. IFN-g can be pro-apoptotic
and IL-12-driven IFN-g inhibits graft-versus-host disease
(GVHD) following hematopoietic stem cell transplantation.We hy-
pothesized that IL-12hi RAPA-DC, unlike control (CTR)-DC
would be effective in the prevention of GVHD by supporting
IFN-g-mediated apoptosis of alloreactive T cells.
Methods: DC were generated from C57BL/6 (H2-b) or BALB/c
(H2-d) bone marrow (BM) in 7 day (d) culture in the presence or ab-
sence of RAPA. DC remained unstimulated or were LPS-stimulated
(100 ng/ml) for an additional 18 hours. CD11c+ DC were used as
stimulators of allogeneic CD4+ T cells in 5 d mixed leukocyte reac-
tion (MLR) with or without anti-IFN-g antibody. T cell apoptosis
was quantified using an Annexin V-PE Apoptosis Detection kit. In-
tracellular FoxP3 expression was determined by flow cytometry. The
capacity of DC to prevent GVHDwas assessed in irradiated BALB/c
mice reconstituted with 5x106 T cell-depleted B6 BM on d0. Recip-
ient mice received 1x106 CD11c+ BALB/c DC (CTR-, RAPA-, or
LPS-exposed DC) on d0 and 1x106 B6 T cells on d1. Mice were
monitored daily, and moribund mice or those with .20% weight
loss were euthanized.
Results: Compared to CTR-DC, especially when LPS-stimulated,
RAPA-DC induced increased apoptosis (Annexin V+7-AAD+) of al-
loreactive CD4+ T cells in MLR (Table 1). Neutralization of IFN-g
in co-cultures containing LPS-stimulated RAPA-DC decreased
levels of apoptosis to those of LPS-exposed CTR-DC. Depletion of
IFN-g did not impact on the Treg-enriching capacity of RAPA-DC.Further, whereas CTR-DC and LPS-exposed CTR-DC did not
prolong survival, LPS-treated RAPA-DC prolonged survival com-
parable to syngeneic controls. RAPA-DC prolonged survival nearing
statistical significance.
LPS-exposed RAPA-DC induce apoptosis of alloreactive CD4+
T cells via an IFN-g dependentmechanism and abrogate acute
GVHD
% CD4+ Annexin V+ Median
Group 7-AAD+ Survival (d)1 Syngeneic - >50d2 CTR-DC 7.1 ± 0.2 8e3 RAPA-DC 13.9 ± 1.6a 25f4 RAPA-DC + aIFNg 21.8 ± 13.7 -
5 CTR-DC + LPS 14.6 ± 3.6 11g6 RAPA-DC + LPS 30.6 ± 3.4b,c >50h7 RAPA-DC + LPS + aIFNg 18.4 ± 1.3 -
8 GVHD - 15ap 5 0.03 compared to group 2.
bp 5 0.04 compared to group 5.
cp 5 0.04 compared to group 7.
dp 5 0.03 compared to group 8.
ep 5 0.92 compared to group 8.
fp 5 0.07 compared to group 8.
gp 5 0.67 compared to group 8.
hp 5 0.005 compared to group 8 by 2-tailed Student’s t-test.
Conclusions: Increased apoptosis of CD4+ allogeneic T cells in-
duced by LPS-stimulated IL-12hi RAPA-DC is mediated through
IFN-g. Thus, increased IL-12 may support IFN-g-mediated activa-
tion-induced cell death while sparing regulatory T cells and underlie
the capacity of LPS-exposed RAPA-DC to prevent GVHD.426
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IL-22 is a recently characterized cytokine that is produced by
helper T cells and innate lymphoid cells (ILC). Expression of its re-
ceptor (IL-22R) is limited to non-hematopoietic stromal cells, and it
mediates protection of intestinal epithelium during experimental co-
litis by providing a signal for epithelial cell survival, proliferation,
and wound healing. We investigated the role of IL-22 in GVHD
during MHC-mismatched C57BL/6 (B6) into BALB/c murine
bone marrow transplantation (BMT). Elimination of IL-22 with
neutralizing antibody led to increased GVHD mortality post-
BMT in comparison to isotype control. IL-22 KO BMT recipients
demonstrated significantly increased GVHD mortality. The critical
role of recipient-derived IL-22 was confirmed in a minor antigen-
mismatched LP into B6 BMTmodel, and IL-22 KO recipients again
demonstrated significantly increased mortality during GVHD and
histopathologic evidence of GVHD in the small and large intestine
and liver. IL-22 ELISA on tissue homogenates following BMT
with wild type donors and recipients indicated that IL-22 levels
were increased post-BMT in small and large intestine. However,
IL-22 was significantly reduced in both tissues during GVHD. We
identified IL-22-producing host ILC in small intestine lamina prop-
ria two weeks post-BMT. ILC were the only IL-22-producing pop-
ulation that could be identified post-BMT, and these ILC were
significantly reduced during GVHD. IL-22R expression was identi-
fied by immunohistochemistry in intestinal crypts where the stem/
progenitor cell niche is located, and immunofluorescence demon-
strated IL-22R expression on intestinal progenitors at the crypt
apex and on intestinal stem cells (ISC) located between lysozyme-ex-
pressing Paneth cells. Use of Lgr5-LacZ reportermice indicated that
ISC were targets of GVHD, and histologic assessment of the ISC
